These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 16308187
1. Evaluation of platelet function, a method comparison. Nylander S, Johansson K, Van Giezen JJ, Lindahl TL. Platelets; 2006 Feb; 17(1):49-55. PubMed ID: 16308187 [Abstract] [Full Text] [Related]
2. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor. Pampuch A, Cerletti C, de Gaetano G. Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371 [Abstract] [Full Text] [Related]
3. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents. Madsen NJ, Holmes CE, Serrano FA, Sobel BE, Schneider DJ. Am J Cardiol; 2007 Aug 15; 100(4):722-7. PubMed ID: 17697836 [Abstract] [Full Text] [Related]
4. The Retention Index Test Homburg (RTH-II): Response to clopidogrel and comparison with aggregometry and CD62P-expression. Klinkhardt U, Wenzel E, Harder S. Platelets; 2006 Feb 15; 17(1):42-8. PubMed ID: 16308186 [Abstract] [Full Text] [Related]
5. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation. Sbrana S, Della Pina F, Rizza A, Buffa M, De Filippis R, Gianetti J, Clerico A. Cytometry B Clin Cytom; 2008 Jan 15; 74(1):30-9. PubMed ID: 17630652 [Abstract] [Full Text] [Related]
6. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W. Thromb Haemost; 2007 Mar 15; 97(3):435-43. PubMed ID: 17334511 [Abstract] [Full Text] [Related]
7. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Storey RF, May JA, Wilcox RG, Heptinstall S. Thromb Haemost; 1999 Oct 15; 82(4):1307-11. PubMed ID: 10544919 [Abstract] [Full Text] [Related]
8. Whole blood aggregometry for evaluation of the antiplatelet effects of clopidogrel. Hochholzer W, Trenk D, Frundi D, Neumann FJ. Thromb Res; 2007 Oct 15; 119(3):285-91. PubMed ID: 16603231 [Abstract] [Full Text] [Related]
9. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets. Mateos-Trigos G, Evans RJ, Heath MF. Platelets; 2002 Oct 15; 13(5-6):285-92. PubMed ID: 12189014 [Abstract] [Full Text] [Related]
10. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia. Mousa SA, Ahmad S. Am J Hematol; 2007 Apr 15; 82(4):276-82. PubMed ID: 17039513 [Abstract] [Full Text] [Related]
14. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia. Awidi A, Maqablah A, Dweik M, Bsoul N, Abu-Khader A. Platelets; 2009 Aug 15; 20(5):297-301. PubMed ID: 19548178 [Abstract] [Full Text] [Related]
15. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor. Dovlatova N, Wijeyeratne YD, Fox SC, Manolopoulos P, Johnson AJ, White AE, Latif ML, Ralevic V, Heptinstall S. Thromb Haemost; 2008 Aug 15; 100(2):261-70. PubMed ID: 18690346 [Abstract] [Full Text] [Related]
16. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy. Béres BJ, Tóth-Zsámboki E, Vargová K, László A, Masszi T, Kerecsen G, Préda I, Kiss RG. Thromb Haemost; 2008 Nov 15; 100(5):829-38. PubMed ID: 18989527 [Abstract] [Full Text] [Related]
20. Influence of extracellular calcium on single platelet activation as measured by whole blood flow cytometry. Hu H, Forslund M, Li N. Thromb Res; 2005 Nov 15; 116(3):241-7. PubMed ID: 15935833 [Abstract] [Full Text] [Related] Page: [Next] [New Search]